top of page
Search
FDA Approves Libtayo for NSCLC With High PD-L1 Expression
Libtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.
Cancer Center Associates
Mar 8, 20212 min read
115 views
TAGRISSO- New Indications for Non Small Cell Lung Cancer!
New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.
Dr. Amanullah Khan MD
Mar 8, 20211 min read
131 views
Acute promyelocytic leukemia (APL) in a patient with Crohn's disease and exposure to infliximab: a
A very rare and possibly one of the few case reports of acute promyelocytic leukemia (APL; acute myeloid leukemia M3, AML-M3) to be reported
Dr. Farhan Mohammad MD
Sep 23, 20201 min read
166 views
Composite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case Report
Composite lymphoma is an extremely rare clinical entity.
Dr. Farhan Mohammad MD
Sep 23, 20203 min read
133 views
0 comments
Patients' Experience with Dr. Khan
U. S. News & World Report When choosing a provider, it can be helpful to review other patients' experiences. U.S. News publishes patient...
Cancer Center Associates
Sep 23, 20201 min read
132 views
0 comments
Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens
Symptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer.
Dr. Farhan Mohammad MD
Sep 23, 20202 min read
59 views
New drug approval by FDA for MDS related anemia
On April 3, 2020, the Food and Drug Administration approved new treatment for MDS related anemia.
Dr. Amanullah Khan MD
Apr 18, 20201 min read
175 views
0 comments
Cancer Center Associates
Apr 16, 20200 min read
121 views
0 comments
Our Response to COVID-19
We are making a few changes to our standard process. Here are the instructions for coming to the office during the COVID-19 pandemic.
Cancer Center Associates
Apr 7, 20201 min read
76 views
0 comments
bottom of page